OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
TPL57

Tamilnadu Petroproducts Ltd

Commodity ChemicalsVerified

Tamilnadu Petroproducts Ltd maintains a strong liquidity position with a current ratio of 2.35, indicating the company can cover its short-term obligations more than twice over. However, the company's free cash flow is negative at -3140521000.0 INR, primarily due to a capital expenditure of -3868667000.0 INR, which suggests significant reinvestment in its operations. The company's debt-to-equity ratio is 0.15, reflecting a relatively low leverage position, which is favorable for financial stability. In terms of profitability, Tamilnadu Petroproducts Ltd reports a return on equity (ROE) of 6.4% and a return on assets (ROA) of 4.31%. These figures are below the industry median for Commodity Chemicals, indicating that the company is underperforming its peers in terms of capital efficiency and asset utilization. The operating margin is 3.16% (calculated from operating income of 574942000.0 INR on revenue of 18267775000.0 INR), which is also below the industry median, suggesting that the company is facing cost pressures or pricing challenges. The company's revenue is concentrated in the Industrial Intermediate Chemicals segment, with Linear Alkyl Benzene being a key product. The geographic exposure is primarily within India, with no significant international operations disclosed. This concentration may limit the company's ability to diversify risk and access new markets. Looking at the growth trajectory, the company's revenue for the latest fiscal year is 18267775000.0 INR. While the company has a history of stable revenue, the outlook for the next fiscal year is uncertain due to the high capital expenditure and negative free cash flow. The company will need to balance its investment in growth with maintaining profitability. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could impact its ability to fund operations without external financing. The dilution risk is low, as the company has not issued additional shares recently, and there is no indication of a significant dilution event in the near term. Recent events include the company's continued investment in its manufacturing facilities in Manali, which is expected to enhance production capacity and efficiency. The company has also been focusing on expanding its product portfolio to include new chemical intermediates, which could drive future growth.

30-day price · TPL+5.45 (+6.6%)
Low$79.55High$93.00Close$88.11As of12 May, 00:00 UTC
Profile
CompanyTamilnadu Petroproducts Ltd
TickerTPL.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Tamilnadu Petroproducts Ltd is engaged in the manufacturing and selling of petrochemical and chemical products, including Linear Alkyl Benzene, Caustic Soda, Chlorine, and Propylene Oxide, primarily serving the Industrial Intermediate Chemicals segment.

Classification. Tamilnadu Petroproducts Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Tamilnadu Petroproducts Ltd maintains a strong liquidity position with a current ratio of 2.35, indicating the company can cover its short-term obligations more than twice over. However, the company's free cash flow is negative at -3140521000.0 INR, primarily due to a capital expenditure of -3868667000.0 INR, which suggests significant reinvestment in its operations. The company's debt-to-equity ratio is 0.15, reflecting a relatively low leverage position, which is favorable for financial stability. In terms of profitability, Tamilnadu Petroproducts Ltd reports a return on equity (ROE) of 6.4% and a return on assets (ROA) of 4.31%. These figures are below the industry median for Commodity Chemicals, indicating that the company is underperforming its peers in terms of capital efficiency and asset utilization. The operating margin is 3.16% (calculated from operating income of 574942000.0 INR on revenue of 18267775000.0 INR), which is also below the industry median, suggesting that the company is facing cost pressures or pricing challenges. The company's revenue is concentrated in the Industrial Intermediate Chemicals segment, with Linear Alkyl Benzene being a key product. The geographic exposure is primarily within India, with no significant international operations disclosed. This concentration may limit the company's ability to diversify risk and access new markets. Looking at the growth trajectory, the company's revenue for the latest fiscal year is 18267775000.0 INR. While the company has a history of stable revenue, the outlook for the next fiscal year is uncertain due to the high capital expenditure and negative free cash flow. The company will need to balance its investment in growth with maintaining profitability. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could impact its ability to fund operations without external financing. The dilution risk is low, as the company has not issued additional shares recently, and there is no indication of a significant dilution event in the near term. Recent events include the company's continued investment in its manufacturing facilities in Manali, which is expected to enhance production capacity and efficiency. The company has also been focusing on expanding its product portfolio to include new chemical intermediates, which could drive future growth.
Key takeaways
  • Tamilnadu Petroproducts Ltd has a strong liquidity position with a current ratio of 2.35 but faces a negative free cash flow due to high capital expenditures.
  • The company's ROE and ROA are below the industry median, indicating underperformance in capital efficiency and asset utilization.
  • Revenue is concentrated in the Industrial Intermediate Chemicals segment, with a primary focus on Linear Alkyl Benzene.
  • The company's growth trajectory is uncertain due to high capital expenditures and negative free cash flow.
  • The company has a medium liquidity risk and a low dilution risk, with no significant dilution events in the near term.
  • Recent investments in manufacturing facilities and product portfolio expansion are expected to drive future growth.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$18.27B
Gross profit$3.01B
Operating income$574.9M
Net income$583.5M
R&D
SG&A
D&A
SBC
Operating cash flow$2.07B
CapEx-$3.87B
Free cash flow-$3.14B
Total assets$13.54B
Total liabilities$4.42B
Total equity$9.12B
Cash & equivalents
Long-term debt$1.35B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.12B
Net cash-$1.35B
Current ratio2.4
Debt/Equity0.1
ROA4.3%
ROE6.4%
Cash conversion3.5%
CapEx/Revenue-21.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricTPLActivity
Op margin3.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin16.5%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-21.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity15.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:55 UTC#df86ea8a
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:57 UTCJob: 1ca33ade